Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Insights, Forecast to 2028

Publisher Name :
Date: 05-Apr-2022
No. of pages: 117
Inquire Before Buying

Circulating Tumor Cells (CTCs) Prognostic Technologies market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells (CTCs) Prognostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Tumor Cell Enrichment

- Tumor Cell Detection

Segment by Application

- Prostate Cancer

- Breast Cancer

- Colorectal Cancer

- Lung Cancer

- Ovarian Cancer

- Pancreatic Cancer

By Company

- AdnaGen

- ACDBio

- Celula

- Epic Sciences

- Fluxion Biosciences

- Rarecells

- Silicon Biosystems

- Vitatex

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Insights, Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tumor Cell Enrichment
1.2.3 Tumor Cell Detection
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Ovarian Cancer
1.3.7 Pancreatic Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Perspective (2017-2028)
2.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Growth Trends by Region
2.2.1 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Historic Market Size by Region (2017-2022)
2.2.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Forecasted Market Size by Region (2023-2028)
2.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Dynamics
2.3.1 Circulating Tumor Cells (CTCs) Prognostic Technologies Industry Trends
2.3.2 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Drivers
2.3.3 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Challenges
2.3.4 Circulating Tumor Cells (CTCs) Prognostic Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTCs) Prognostic Technologies Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTCs) Prognostic Technologies Players by Revenue (2017-2022)
3.1.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Market Share by Players (2017-2022)
3.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue
3.4 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in 2021
3.5 Circulating Tumor Cells (CTCs) Prognostic Technologies Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells (CTCs) Prognostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTCs) Prognostic Technologies Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Historic Market Size by Type (2017-2022)
4.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Forecasted Market Size by Type (2023-2028)
5 Circulating Tumor Cells (CTCs) Prognostic Technologies Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Historic Market Size by Application (2017-2022)
5.2 Global Circulating Tumor Cells (CTCs) Prognostic Technologies Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2017-2028)
6.2 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
6.2.1 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022)
6.2.2 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028)
6.2.3 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2017-2028)
6.3 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application
6.3.1 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022)
6.3.2 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028)
6.3.3 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2017-2028)
6.4 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country
6.4.1 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2017-2022)
6.4.2 North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2017-2028)
7.2 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
7.2.1 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022)
7.2.2 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028)
7.2.3 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2017-2028)
7.3 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application
7.3.1 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022)
7.3.2 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028)
7.3.3 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2017-2028)
7.4 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country
7.4.1 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2017-2022)
7.4.2 Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2017-2028)
8.2 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
8.2.1 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2017-2028)
8.3 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application
8.3.1 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2017-2028)
8.4 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Region
8.4.1 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2017-2028)
9.2 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
9.2.1 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022)
9.2.2 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028)
9.2.3 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2017-2028)
9.3 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application
9.3.1 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022)
9.3.2 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028)
9.3.3 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2017-2028)
9.4 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country
9.4.1 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2017-2022)
9.4.2 Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (2017-2028)
10.2 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type
10.2.1 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type (2017-2028)
10.3 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application
10.3.1 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application (2017-2028)
10.4 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country
10.4.1 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AdnaGen
11.1.1 AdnaGen Company Details
11.1.2 AdnaGen Business Overview
11.1.3 AdnaGen Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
11.1.4 AdnaGen Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
11.1.5 AdnaGen Recent Developments
11.2 ACDBio
11.2.1 ACDBio Company Details
11.2.2 ACDBio Business Overview
11.2.3 ACDBio Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
11.2.4 ACDBio Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
11.2.5 ACDBio Recent Developments
11.3 Celula
11.3.1 Celula Company Details
11.3.2 Celula Business Overview
11.3.3 Celula Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
11.3.4 Celula Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
11.3.5 Celula Recent Developments
11.4 Epic Sciences
11.4.1 Epic Sciences Company Details
11.4.2 Epic Sciences Business Overview
11.4.3 Epic Sciences Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
11.4.4 Epic Sciences Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
11.4.5 Epic Sciences Recent Developments
11.5 Fluxion Biosciences
11.5.1 Fluxion Biosciences Company Details
11.5.2 Fluxion Biosciences Business Overview
11.5.3 Fluxion Biosciences Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
11.5.4 Fluxion Biosciences Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
11.5.5 Fluxion Biosciences Recent Developments
11.6 Rarecells
11.6.1 Rarecells Company Details
11.6.2 Rarecells Business Overview
11.6.3 Rarecells Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
11.6.4 Rarecells Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
11.6.5 Rarecells Recent Developments
11.7 Silicon Biosystems
11.7.1 Silicon Biosystems Company Details
11.7.2 Silicon Biosystems Business Overview
11.7.3 Silicon Biosystems Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
11.7.4 Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
11.7.5 Silicon Biosystems Recent Developments
11.8 Vitatex
11.8.1 Vitatex Company Details
11.8.2 Vitatex Business Overview
11.8.3 Vitatex Circulating Tumor Cells (CTCs) Prognostic Technologies Introduction
11.8.4 Vitatex Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
11.8.5 Vitatex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tumor Cell Enrichment
Table 3. Key Players of Tumor Cell Detection
Table 4. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Region (2017-2022)
Table 8. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Region (2023-2028)
Table 10. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Trends
Table 11. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Drivers
Table 12. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Challenges
Table 13. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Restraints
Table 14. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Share by Players (2017-2022)
Table 16. Global Top Circulating Tumor Cells (CTCs) Prognostic Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies as of 2021)
Table 17. Ranking of Global Top Circulating Tumor Cells (CTCs) Prognostic Technologies Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Circulating Tumor Cells (CTCs) Prognostic Technologies Product Solution and Service
Table 21. Date of Enter into Circulating Tumor Cells (CTCs) Prognostic Technologies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Market Share by Type (2017-2022)
Table 25. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Market Share by Type (2023-2028)
Table 27. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Share by Application (2017-2022)
Table 29. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue Share by Application (2023-2028)
Table 31. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size by Country (2023-2028) & (US$ Million)
Table 61. AdnaGen Company Details
Table 62. AdnaGen Business Overview
Table 63. AdnaGen Circulating Tumor Cells (CTCs) Prognostic Technologies Product
Table 64. AdnaGen Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022) & (US$ Million)
Table 65. AdnaGen Recent Developments
Table 66. ACDBio Company Details
Table 67. ACDBio Business Overview
Table 68. ACDBio Circulating Tumor Cells (CTCs) Prognostic Technologies Product
Table 69. ACDBio Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022) & (US$ Million)
Table 70. ACDBio Recent Developments
Table 71. Celula Company Details
Table 72. Celula Business Overview
Table 73. Celula Circulating Tumor Cells (CTCs) Prognostic Technologies Product
Table 74. Celula Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022) & (US$ Million)
Table 75. Celula Recent Developments
Table 76. Epic Sciences Company Details
Table 77. Epic Sciences Business Overview
Table 78. Epic Sciences Circulating Tumor Cells (CTCs) Prognostic Technologies Product
Table 79. Epic Sciences Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022) & (US$ Million)
Table 80. Epic Sciences Recent Developments
Table 81. Fluxion Biosciences Company Details
Table 82. Fluxion Biosciences Business Overview
Table 83. Fluxion Biosciences Circulating Tumor Cells (CTCs) Prognostic Technologies Product
Table 84. Fluxion Biosciences Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022) & (US$ Million)
Table 85. Fluxion Biosciences Recent Developments
Table 86. Rarecells Company Details
Table 87. Rarecells Business Overview
Table 88. Rarecells Circulating Tumor Cells (CTCs) Prognostic Technologies Product
Table 89. Rarecells Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022) & (US$ Million)
Table 90. Rarecells Recent Developments
Table 91. Silicon Biosystems Company Details
Table 92. Silicon Biosystems Business Overview
Table 93. Silicon Biosystems Circulating Tumor Cells (CTCs) Prognostic Technologies Product
Table 94. Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022) & (US$ Million)
Table 95. Silicon Biosystems Recent Developments
Table 96. Vitatex Company Details
Table 97. Vitatex Business Overview
Table 98. Vitatex Circulating Tumor Cells (CTCs) Prognostic Technologies Product
Table 99. Vitatex Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022) & (US$ Million)
Table 100. Vitatex Recent Developments
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Type: 2021 VS 2028
Figure 2. Tumor Cell Enrichment Features
Figure 3. Tumor Cell Detection Features
Figure 4. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Application: 2021 VS 2028
Figure 5. Prostate Cancer Case Studies
Figure 6. Breast Cancer Case Studies
Figure 7. Colorectal Cancer Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Ovarian Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Circulating Tumor Cells (CTCs) Prognostic Technologies Report Years Considered
Figure 12. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Region: 2021 VS 2028
Figure 15. Global Circulating Tumor Cells (CTCs) Prognostic Technologies Market Share by Players in 2021
Figure 16. Global Top Circulating Tumor Cells (CTCs) Prognostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTCs) Prognostic Technologies as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTCs) Prognostic Technologies Revenue in 2021
Figure 18. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Type (2017-2028)
Figure 20. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Application (2017-2028)
Figure 21. North America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Country (2017-2028)
Figure 22. United States Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Type (2017-2028)
Figure 26. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Application (2017-2028)
Figure 27. Europe Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Country (2017-2028)
Figure 28. Germany Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Region (2017-2028)
Figure 38. China Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Country (2017-2028)
Figure 48. Mexico Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size Share by Country (2017-2028)
Figure 54. Turkey Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Circulating Tumor Cells (CTCs) Prognostic Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
Figure 58. ACDBio Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
Figure 59. Celula Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
Figure 60. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
Figure 61. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
Figure 62. Rarecells Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
Figure 63. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
Figure 64. Vitatex Revenue Growth Rate in Circulating Tumor Cells (CTCs) Prognostic Technologies Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs